Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Chiang

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Acta Neuropathologica|August 11, 2025
Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysisMargit K Mikkelsen, Xiaoyu Li, Kaiwen Yu, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Acta Neuropathologica|August 11, 2025
Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysisMargit K Mikkelsen, Xiaoyu Li, Kaiwen Yu, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Pageof 14